pentoxifylline has been researched along with Sarcoidosis in 6 studies
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
Excerpt | Relevance | Reference |
---|---|---|
"We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine." | 7.88 | [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report]. ( Diallo, BD; Diot, B; Diot, P; Flament, T; Marchand-Adam, S; Plantier, L; Sow, OY, 2018) |
"The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate." | 4.84 | Cutaneous sarcoidosis therapy updated. ( Badgwell, C; Rosen, T, 2007) |
"We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine." | 3.88 | [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report]. ( Diallo, BD; Diot, B; Diot, P; Flament, T; Marchand-Adam, S; Plantier, L; Sow, OY, 2018) |
"Pentoxifylline (PTX) is a methylxanthine derivative with a variety of anti-inflammatory effects." | 2.44 | Pentoxifylline: a drug with wide spectrum applications in dermatology. ( Zargari, O, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diallo, BD | 1 |
Diot, B | 1 |
Flament, T | 1 |
Plantier, L | 1 |
Diot, P | 1 |
Sow, OY | 1 |
Marchand-Adam, S | 1 |
Zargari, O | 1 |
Antoniu, SA | 1 |
Moller, DR | 1 |
Badgwell, C | 1 |
Rosen, T | 1 |
Körber, M | 1 |
Kamp, S | 1 |
Kothe, H | 1 |
Braun, J | 1 |
Dalhoff, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata: a Clinical and Dermoscopic Study.[NCT06087796] | Phase 1 | 60 participants (Anticipated) | Interventional | 2023-10-31 | Not yet recruiting | ||
Clinical Biomarkers of Disease Activity and Treatment Responses in Patients With CNS Sarcoidosis Treated With H.P. Acthar Gel[NCT02298491] | Phase 4 | 4 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Total number of lesions assessed at 1 year (NCT02298491)
Timeframe: 1 year
Intervention | lesions (Number) |
---|---|
H.P. Acthar Gel | 5 |
4 reviews available for pentoxifylline and Sarcoidosis
Article | Year |
---|---|
Pentoxifylline: a drug with wide spectrum applications in dermatology.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Behcet Syndrome; C | 2008 |
Targeting the TNF-alpha pathway in sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Eta | 2010 |
Treatment of sarcoidosis -- from a basic science point of view.
Topics: Etanercept; Granuloma; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukins; Pentoxifyll | 2003 |
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents | 2007 |
2 other studies available for pentoxifylline and Sarcoidosis
Article | Year |
---|---|
[The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report].
Topics: Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Pentoxifylline | 2018 |
[Pentoxifylline inhibits secretion of O2- and TNF-alpha by alveolar macrophages in patients with sarcoidosis].
Topics: Adult; Female; Humans; In Vitro Techniques; Macrophages, Alveolar; Male; Pentoxifylline; Respiratory | 1995 |